| Filed | Form | Description | |
|---|---|---|---|
| 4/10/25 | DEFA14A | DEFA14A | → |
| 4/10/25 | DEF 14A | DEF 14A | → |
| 3/27/25 | PRE 14A | PRE 14A | → |
| 11/1/24 | DEFA14A | DEFA14A | → |
| 10/9/24 | DEFA14A | DEFA14A | → |
| 10/4/24 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/6/26 | 4 | 4 | → |
| 2/27/26 | 4 | 4 | → |
| 2/27/26 | 4 | 4 | → |
| 2/25/26 | 4 | 4 | → |
| 2/25/26 | 4 | 4 | → |
| 2/18/26 | 4 | 4 | → |
| ↓ | |||
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.